PolarCool signs first English Championship Rugby agreement with Doncaster Knights

Report this content

PolarCool AB (publ) has entered into a two-year agreement with the English Championship Rugby team, Doncaster Knights, for the use of the PolarCap® System. The agreement marks PolarCool's first entry into the English Championship, the second professional tier of English Rugby.

PolarCool develops and markets the product PolarCap®, which alleviates the effects of concussions. The primary users of PolarCap® include sports clubs, organizations, and facilities in contact sports such as ice hockey, rugby, football, and handball, but also other sports with an increased risk of concussion.

The agreement with Doncaster Knights represents an important entrance into the second professional tier in English rugby. Despite low budgets in English Championship Rugby, Doncaster Knights' prioritization of providing treatment with PolarCap® shows their commitment to player welfare and advancing the care of their athletes.

PolarCool's CEO Erik Andersson comments:

-We are thrilled to partner with Doncaster Knights to introduce PolarCap® into the English Championship. This agreement shows our shared commitment to player safety and well-being. We look forward to supporting the Knights in advancing concussion management in rugby.

Sir Ian McGeechan, Doncaster Knights' Director of Rugby, has been instrumental in the team providing the treatment. Sir Ian McGeechan is a renowned figure in rugby, known for his successful coaching career with the British and Irish Lions, as well as his extensive experience and contributions to the sport.

The agreement with Doncaster Knights is strategically important, even if the financial significance of individual agreements is limited.

For more information

Erik Andersson –  CEO PolarCool AB (publ.)               
+46 - 738 60 57 00                                         
E-mail: erik.andersson@polarcool.se
 

About PolarCool AB (publ.)

PolarCool AB (publ.) is a medical device company that develops, markets, and sells products for sports medicine. The company focuses on treatment of concussive and sub-concussive brain injury with the portable cooling device PolarCap® System. PolarCool AB (publ.) is based in Lund, Sweden, and its shares are listed on Spotlight Stock Market.